Pharma: Other News To Note
Janssen-Cilag International NV, of Beerse, Belgium, said the Committee for Medical Products for Human Use of the European Medicines Agency (EMA) recommended approval of subcutaneous administration of Velcade (bortezomib), indicated for multiple myeloma.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST